| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$41 |
Update - Notification of buy-back - EPY
|
7 Apr 2026 8:41AM |
$0.155 |
$0.160 |
risen by
3.23%
|
|
| De.mem Limited (DEM) ORDINARY FULLY PAID |
Utilities |
$28 |
Notification of cessation of securities - DEM
|
7 Apr 2026 8:41AM |
$0.093 |
$0.086 |
fallen by
7.53%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$173,453 |
Statement of CDIs on issue - NEM
|
7 Apr 2026 8:41AM |
$159.330 |
$159.680 |
risen by
0.22%
|
|
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$5,803 |
BOQ: BOQ Announces Capital Partnership with Challenger
|
7 Apr 2026 8:41AM |
$8.260 |
$8.390 |
risen by
1.57%
|
|
CGF - Price-sensitive ASX Announcement
Full Release
Key Points
- BOQ announces a strategic capital partnership with Challenger Limited.
- The partnership involves a whole-of-loan sale and a forward flow arrangement.
- It aims to optimize BOQ’s funding base and support growth in equipment finance for small to medium businesses.
- The transaction is expected to complete by May 2026, reducing debt funding and returning ~$300 million to shareholders.
- The whole-of-loan sale is valued at $3.7 billion, with a $25 million provision release.
- Challenger will manage direct credit risk exposure, while BOQ continues managing customer relationships.
- The partnership is expected to enhance Return on Equity (ROE) and Earnings Per Share (EPS) for BOQ.
- The agreement allows BOQ to leverage its capacity in equipment finance, particularly in the SME sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bank of Queensland Limited (BOQ) ORDINARY FULLY PAID |
Financials |
$4,835 |
BOQ Announces Capital Partnership with Challenger
|
7 Apr 2026 8:41AM |
$6.800 |
$7.310 |
risen by
7.50%
|
|
BOQ - Price-sensitive ASX Announcement
Full Release
Key Points
- BOQ announces strategic partnership with Challenger.
- Partnership includes whole-of-loan sale and forward flow arrangement.
- Transaction aims to optimize BOQ's funding base and expand SME services.
- Expected to enhance shareholder returns and improve ROE and EPS.
- Involves a $3.7 billion whole-of-loan sale reducing debt funding.
- Capital return to shareholders through buyback and special dividend.
- Challenger assumes direct credit risk in forward flow arrangement.
- BOQ retains flexibility in originating and servicing finance facilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Yancoal Australia Limited (YAL) ORDINARY FULLY PAID |
Energy |
$8,715 |
Appendix 3H
|
7 Apr 2026 8:41AM |
$8.270 |
$6.600 |
fallen by
20.19%
|
|
| IVE Group Limited (IGL) ORDINARY FULLY PAID |
Communication Services |
$412 |
Update - Notification of buy-back - IGL
|
7 Apr 2026 8:41AM |
$2.640 |
$2.680 |
risen by
1.52%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$80 |
Amplia Therapeutics Halts Recruitment in AMPLICITY Trial
|
7 Apr 2026 8:40AM |
$0.240 |
$0.155 |
fallen by
35.42%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia Therapeutics Limited announced the halt of recruitment in the AMPLICITY trial.
- The decision was influenced by interim data analysis and the competitive treatment landscape.
- Amplia focuses on the development of Focal Adhesion Kinase inhibitors for cancer treatment.
- The company plans to reassess the trial's focus and explore potential partnerships.
- Amplia remains committed to its clinical development strategy despite the recruitment halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DPM Metals Inc. (DPM) CDI 1:1 FOREIGN EXEMPT TSX |
Materials |
$13,038 |
2025 Annual Report
|
7 Apr 2026 8:40AM |
$52.570 |
$54.310 |
risen by
3.31%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,681 |
Net Tangible Asset Backing
|
7 Apr 2026 8:38AM |
$3.960 |
$4.230 |
risen by
6.82%
|
|
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$48 |
EXCEPTIONAL ASSAY RESULTS UP TO 53.2% CAF2 AT MAMMOTH
|
7 Apr 2026 8:36AM |
$0.100 |
$0.185 |
risen by
85%
|
|
OD6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Exceptional assay results up to 53.2% CaF2 from Mammoth Prospect.
- High-grade fluorspar mineralization confirmed over a large target zone.
- Potential for expansion of high-grade system to the west, north, and east.
- OD6 Metals aiming to establish a premier fluorspar project.
- Company is well-funded to accelerate exploration and drilling programs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vmoto Limited (VMT) ORDINARY FULLY PAID |
Consumer Discretionary |
$40 |
Initial Director's Interest Notice
|
7 Apr 2026 8:35AM |
$0.077 |
$0.100 |
risen by
29.87%
|
|
| Vmoto Limited (VMT) ORDINARY FULLY PAID |
Consumer Discretionary |
$40 |
Final Director's Interest Notice
|
7 Apr 2026 8:35AM |
$0.077 |
$0.100 |
risen by
29.87%
|
|
| US Masters Residential Property Fund (URF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$127 |
Notification of buy-back - URF
|
7 Apr 2026 8:34AM |
$0.180 |
$0.185 |
risen by
2.78%
|
|
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$69 |
Update - Notification of buy-back - BOL
|
7 Apr 2026 8:33AM |
$1.750 |
$1.800 |
risen by
2.86%
|
|
| Infragreen Group Limited (IFN) ORDINARY FULLY PAID |
Industrials |
$47 |
Strategic Review
|
7 Apr 2026 8:33AM |
$0.350 |
$0.350 |
fallen by
0%
|
|
IFN - Price-sensitive ASX Announcement
Full Release
Key Points
- Infragreen Group Limited has announced a strategic review of its business.
- The review is in response to the recent share price performance not reflecting the company's actual value.
- The strategic review will evaluate options to unlock shareholder value.
- Lindsay Ward, Infragreen’s Chairman, will lead the review with external advisers.
- The review will consider potential transactions and capital management initiatives.
- There is no certainty of any specific outcome from the review.
- Shareholders will be updated, with the first update expected by end of May 2026.
- Infragreen focuses on infrastructure businesses with a strong emphasis on sustainability.
- The company operates primarily in Australia and New Zealand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$286 |
Application for quotation of securities - SPL
|
7 Apr 2026 8:32AM |
$0.500 |
$0.680 |
risen by
36%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
Update - Notification of buy-back - MEC
|
7 Apr 2026 8:32AM |
$1.130 |
$1.210 |
risen by
7.08%
|
|
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,130 |
Q3 FY26 Quarterly Sales Update
|
7 Apr 2026 8:31AM |
$15.200 |
$21.040 |
risen by
38.42%
|
|
GYG - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong sales growth driven by demand for fresh food.
- Operational excellence and network expansion with five new openings in Australia.
- Strategic partnership with Uber Eats to improve delivery services.
- Positive results from proprietary order management system in drive-thrus.
- Sales in the US segment improved with two new restaurant openings.
- Reaffirmed guidance anticipates EBITDA growth and expansion plans.
- 32 new restaurants planned in Australia for FY26, including 23 drive-thrus.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,427 |
Update - Notification of buy-back - KAR
|
7 Apr 2026 8:31AM |
$2.120 |
$2.000 |
fallen by
5.66%
|
|
| Ballard Mining Limited (BM1) ORDINARY FULLY PAID |
Materials |
$209 |
Mt Ida Project Development and Early Works Update
|
7 Apr 2026 8:31AM |
$0.660 |
$0.700 |
risen by
6.06%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$55,317 |
Notice of Proposed Sale of Securities
|
7 Apr 2026 8:31AM |
$84.520 |
$98.860 |
risen by
16.97%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$55,317 |
Notice of Proposed Sale of Securities
|
7 Apr 2026 8:31AM |
$84.520 |
$98.860 |
risen by
16.97%
|
|
| ImpediMed Limited (IPD) ORDINARY FULLY PAID |
Health Care |
$29 |
Appointment of CEO/Managing Director
|
7 Apr 2026 8:31AM |
$0.016 |
$0.014 |
fallen by
9.68%
|
|
IPD - Price-sensitive ASX Announcement
Full Release
Key Points
- Erik Anderson appointed as CEO and Managing Director effective 7 April 2026.
- Dr Parmjot Bains to continue as an advisor until 30 June 2026 to ensure a smooth transition.
- ImpediMed focuses on accelerating revenue growth and strengthening health system engagement in the US.
- Mr. Anderson's previous role was Division President at Hologic’s Breast and Skeletal Health business.
- Under Dr. Bains, ImpediMed expanded its market with new clinical indications and increased reimbursement coverage in the US.
- Mr. Anderson’s appointment aims to drive adoption of the SOZO platform and lead the company towards profitability.
- Employment terms for Mr. Anderson include a base salary of US$350,000 and potential transformation incentives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$87 |
Notification of cessation of securities - CYP
|
7 Apr 2026 8:31AM |
$0.295 |
$0.365 |
risen by
23.73%
|
|
Call 1300 880 160
Start a chat
Schedule a call
